Patent ID: 9249130
Filing Date: 2016-02-02
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A method of treatment of an attention related disorder, which method comprises the administration of an effective amount of a compound of formula A1: wherein: A represents Cy Cy Het B represents a Cy Cy Het R (a) halo, (b) CN, (c) C (d) Cy (e) Het (f) OR (g) S(O) (h) S(O) (i) N(R (j) N(R (k) B (l) ═O, (m) ═S, or when two R G R H, Cy Het Cy Het R (a) H, (b) C (c) aryl or (d) C B each aryl each aryl independently represents a C C —OR Het halo, C —OR R H, C R (a) H; (b) C (c) S(O) (d) S(O) (e) C(O)—B R (a) H, (b) C (c) C (d) Het G R (a) H, (b) C (c) C (d) Het or R B aryl C C R H, C Het Het q and r independently represent at each occurrence 0, 1 or 2; and unless otherwise specified alkyl, alkenyl, alkynyl, cycloalkyl and the alkyl part of alkoxy groups may be substituted by one or more halo atoms; or a pharmaceutically acceptable salt or solvate, or a pharmaceutically functional derivative thereof, provided that the compound is not: (a) 5-(2-chlorophenyl)-6-(3,4-dimethoxyphenyl)-[1,2,4]triazin-3-ylamine; or (b) 5-(2-chlorophenyl)-6-(3,4,5-trimethoxyphenyl)-[1,2,4]triazin-3-ylamine.